<DOC>
	<DOCNO>NCT00174733</DOCNO>
	<brief_summary>To investigate efficacy ciclesonide MDI either daily twice daily regimen patient mild moderate asthma , previously treat inhaled corticosteroid .</brief_summary>
	<brief_title>Efficacy Ciclesonide Versus Placebo Administered Either Once Daily Twice Daily Patients Treated Previously With Inhaled Corticosteroid</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Males females 12 year old History persistent bronchial asthma least 6 month Documented use inhale steroid combination inhale steroid/longacting beta 2 agonist least 1 month screening At screening , FEV1 60 90 % predict 70 95 % predict either ICS ICS/LABA use respectively.Reversibility FEV1 least 12 % 200 ml postbronchodilator Be able use oral inhaler Nonsmokers History lifethreatening asthma Other pulmonary disease ; URI within 4 week screen Use systemic steroid within 1 month screen 3 time previous 6 month Betaadrenergic block agent use More 2 inpatient hospitalization ER visit due asthma exacerbation prior year screen Pregnant breastfeeding female Females childbearing potential use adequate mean birth control Clinically relevant cardiovascular , hepatic , neurologic , endocrine , major systemic disease Abnormal clinical laboratory parameter would limit participation study interfere interpretation study result History drug alcohol abuse Treatment investigational product within 30 day prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Glucocorticosteroid . Bronchospasm</keyword>
</DOC>